The Lancet Oncology in conversation with artwork

Mike Sathekge on radioligand therapy of metastatic castration-resistant prostate cancer

The Lancet Oncology in conversation with

English - January 29, 2024 23:00 - 16 minutes - 11.1 MB - ★★★★★ - 1 rating
Medicine Health & Fitness Education cancer radiotherapy chemotherapy mrna Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Shankar Shiva on stereotactic body radiotherapy for primary renal cell carcinoma

Next Episode: Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers

Professor Mike Sathekge (Department of Nuclear Medicine, University of Pretoria, Pretoria, South Africa) discusses his Article entitled, ‘Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre retrospective study.’

Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00638-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Twitter Mentions